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Summary The association between breast and endometrial cancer was investigated in a cohort consisting of
60,065 subjects (99% of all women in whom a first breast cancer was diagnosed in Sweden in 1960-63 and
1968-81). Complete follow-up until 1981 revealed a total of 260 endometrial cancers, as against an expected
number of 151.1 (relative risk (RR)= 1.72; 95% confidence limits (CL) 1.46; 1.87). RR increased steadily
from close to unity in women younger than 50 at breast cancer diagnosis to 2.40 (CL 1.97; 2.93) in those 70
years of age and older. The excess number of endometrial cancers occurred primarily during the first five
years of follow-up (RR=2.07; CL 1.79; 2.38). A common causal agency for breast and endometrial cancer is
more likely to lie in environmental than in genetic factors and other observations in the same population do
not support that such factors are related to characteristics of the women's reproductive histories.
Breast and endometrial cancers are generally believed to
have aetiologic factors in common, primarily of a dietary
and endocrine origin (Dunn, 1975; Cole & Cramer, 1977;
Howe et al., 1984; Henderson et al., 1982; Willett &
MacMahon, 1984). Descriptive epidemiologic studies have
revealed high correlations between breast and endometrial
cancer with regard to incidence and mortality rates. Such
observations have been reported from international
investigations in both low- and high-risk countries and in
migrant populations (Dunn, 1975) and also from different
parts of high-risk countries such as Canada (Howe et al.,
1984) and the United States (Hoover et al., 1975;
Winkelstein et al., 1977).
The possibility that these demographic correlations reflect
common genetic or environmental aetiologic factors has
gained some support from cohort studies in which an
increased risk of endometrial cancer has been found in
breast cancer patients (Schoenberg et al., 1969) and vice
versa (Schottenfeld & Berg, 1971; Bailar, 1963; MacMahon
& Austin, 1969). The knowledge that can be derived from
these analytic studies is generally uncertain, however,
because of small numbers of cases, contradictory findings in
blacks and whites (Newell et al., 1974), and limited
information as to the possible dependence of an association
between breast and endometrial cancer on age at diagnosis
of the first primary (Bailar, 1963; MacMahon & Austin,
1969). The aim of this investigation was to confirm and
extend in a larger cohort our recent finding that the
association between breast and endometrial cancer is
seemingly restricted to older women (Adami et al., 1984).
The availability of a national cancer registry, reliable
incidence figures for the studied population and oppor-




Since 1958, when the National Swedish Cancer Registry was
started, all newly diagnosed malignant tumours have had to
be reported to the Registry. This obligation rests upon both
the physician and the pathologist or cytologist who confirms
the diagnosis on surgically removed tissues, biopsies,
cytologic specimens or at autopsy. As a result, -95% of the
cases entered in the Registry are notified from two sources.
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The overall frequency of underreporting has been shown to
be - 5% (Mattsson, 1977) and the completeness of
registration of breast and endometrial cancer has been
assessed from death certificates to be 98 and 95%
respectively (Mattsson & Wallgren, 1984).
The cohort was based on all women reported as having a
first breast cancer diagnosed in 1960 through 1963 and 1968
through 1981. The four-year period of our previous study
(Adami et al., 1984), 1964 through 1967, was excluded, since
one major aim was to rule out the possibility that the excess
risk previously found was due to chance (type I error) i.e. to
a random high relative risk among the large number of
tumour sites and subgroups that were analysed. Patients
were included irrespective of whether they had had any other
malignant disease reported prior to the breast cancer.
A total of 61,341 women with breast cancer were notified
to the Cancer Registry during the period of study. We
excluded 583 women with an incomplete national
registration number (a number which permits exclusive
identification), precluding computerized linkages and follow-
up in the Cancer Registry and other registers. The breast
cancer of a total of 693 patients had been diagnosed at
autopsy and these patients were therefore not included in the
study. As a result, 60,065 women with the age distribution
shown in Table I were available for complete follow-up and
comprised the study cohort.
Person-years at risk
The cancer file is linked annually to the Register of Causes
of Death, which covers the entire Swedish population. The
date of death - which was the only information used in this
analysis - and the causes of death are then transferred. At
the time of this study the Register was complete up to
December 31 1981, giving a follow-up period of 0-20
completed years. The cohort was also linked through the
national registration numbers with a national register
covering all persons who emigrate.
The person-years at risk were calculated from the date of
the breast cancer diagnosis. The date of the first diagnosis
was used in those 3023 women who - most probably because
of a metachronous bilateral disease - were registered more
than once for breast cancer. The end of the observation time
was defined as the date of endometrial cancer diagnosis,
emigration or death, or the closing date of follow-up. By this
latter time 55 (0.1%) patients had emigrated and 28,362
(47.2%) had died. The proportions of patients in the cohort
observed for at least 5 and 10 completed years were 38.5 and
14.7% respectively. The number of person-years at risk is
shown in Table I.
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E.vpected incidence of endometrial cancer
Official statistics from the Swedish Cancer Registry (Swedish
Board of Health and Welfare. Stockholm 1963-1985)
provided age-specific incidence rates for each year of
observation. The expected number of persons with
endometrial cancer in the cohort was obtained by
multiplication of person-years for different 5-year age groups
for each year of observation by the corresponding age-
specific incidence rates.
Observed incidence of endometrial cancer
The register of the cohort was linked through the national
registration numbers to the entire Cancer Registry covering
the whole Swedish population for the period 1960 through
1981. All endometrial cancers diagnosed during the same
month as the breast cancer or during any subsequent month
were regarded as second primary cancers. A detection bias
might have exaggerated the incidence of endometrial cancer
that was diagnosed at the same time as the breast cancer or
at autopsy. The cases in which this happened were therefore
analysed separately.
Statistical methods
The relative risk was defined as the ratio of observed
numbers of cases of endometrial cancer to expected numbers.
The 95% confidence limits (CL) of the relative risk were
then calculated on the assumption that the observed number
of cases follows the Poisson distribution (Bailar & Ederer,
1964).
Table II Relative risk (RR) of developing endometrial cancer with
95% confidence limits (CL) by age at breast cancer diagnosis
Age at breast cancer
diagnosis, years Expected Observed RR CL
<40 2.1 2 0.95 0.12-3.44
40-49 24.9 27 1.08 0.72-1.58
50-59 39.1 55 1.41 1.06-1.83
60-69 44.2 78 1.76 1.40-2.20
70-79 31.5 75 2.38 1.87-2.98
80+ 9.3 23 2.47 1.57-3.71





Table I Distribution of the cohort by age at breast cancer
diagnosis with number of person-years at risk
Age at diagnosis, Person-
years Number Per cent years
<40 2,723 4.5 15,890
40-49 8,939 14.9 62,895
50-59 12,662 21.1 73,884
60-69 15,184 25.3 80,148
70-79 13,692 22.8 55,983
80+ 6,865 11.4 18,952
All ages 60,065 100.0 307,754
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Results
A total of 260 women in the cohort developed endometrial
cancer, as against an expected number of 151.1 (RR= 1.72)
Every case of endometrial cancer in the cohort was
confirmed histopathologically, as compared with 99.7% of
all such tumours in the Cancer Registry. There was a regular
trend towards an increase in relative risk, from a value close
to unity (RR = 1.07; CL 0.72-1.54) in women younger than
50 years at breast cancer diagnosis to 2.47 (CL 1.57-3.71) in
those 80 years or older (Table II). The relative risk for all
women 70 years and older was 2.40 (CL 1.97-2.93) which is
the same figure as in our previous report (Adami et al.,
1984).
The cumulative numbers of expected and observed cases
of endometrial cancer for each year of observation is
presented in Figure I and the relative risk in relation to the
duration of follow-up is shown in Table III. The increased
risk was greatest in the first years after the breast cancer
diagnosis. Analyses by each year revealed relative risks of
2.51, 1.60, 2.11, 1.79 and 2.05 consecutively during the first 5
years of observation. The highest risk was incurred during
the first year after diagnosis by patients 70 years of age or
older, with 37 observed versus 9.89 expected cases of
endometrial cancer (RR=3.74; CL 2.64-5.16).
Years after breast cancer diagnosis
Figure 1 Cumulative numbers of expected (x) and observed
(0) cases of endometrial cancer in the cohort of breast cancer
patients for each year of observation.
Two possibilities of bias were specially analyzed. Firstly,
the diagnosis of a breast cancer might have increased the
likelihood of having the date of diagnosis advanced for a
limited period of time in some women whose endometrial
cancer was already symptomatic. A total of 28 (38%) of 66
endometrial cancers which occurred during the first year of
observation were in fact diagnosed during the same month
as the breast cancer. Exclusion of these 25 cases would not,
however, have altered the general pattern of the results or
the regular trend towards an increase in relative risk with
increasing age.
Secondly, the question of ascertainment bias was
addressed. The incidence of endometrial cancer among
breast cancer patients might have been over- or under-
estimated as a result of a higher or lower rate of autopsy
in such patients than in the general population from which
the incidence figures were derived. However, as shown in
Table IV, the proportion of endometrial cancers diagnosed
at autopsy was of approximately the same low magnitude in
both groups of women.BREAST AND ENDOMETRIAL CANCER 79
Table III Relative risk (RR) of developing endometrial cancer, with 95% confidence limits (CL) among women with breast cancer
by age at diagnosis and duration of follow-up in completed years
Duration offollow-up, years
Age at 0-4 5-9 10+
diagnosis,
years Exp. Obs. RR CL Exp. Obs. RR CL Exp. Obs. RR CL
< 50 10.50 13 1.24 0.66-2.12 8.72 7 0.80 0.32-1.65 7.76 9 1.16 0.53-2.20
50-59 22.58 37 1.64 1.16-2.26 10.42 11 1.06 0.53-1.89 6.13 7 1.14 0.46-2.35
60-69 27.82 55 1.98 1.49-2.57 11.43 19 1.66 1.00-2.60 4.97 4 0.80 0.22-2.06
70+ 31.49 86 2.73 2.19-3.38 7.74 10 1.29 0.62-2.38 1.54 2 1.30 0.16-4.69
All ages 92.39 191 2.07 1.79-2.38 38.31 47 1.23 0.90-1.63 20.40 22 1.08 0.68-1.63
Table IV Number and per cent of all endometrial cancers
diagnosed at autopsy in the entire Cancer Registry 1960-1981
and in the breast cancer cohort by age at diagnosis
Cancer Registry Cohort
Age, years Number Per cent Number Per cent
<40 1/196 0.5 0/0 0
40-49 13/1886 0.7 1/9 11.1
50-59 84/5321 1.6 3/41 7.3
60-69 196/5021 3.9 2/79 2.5
70-79 242/3593 6.7 5/89 5.6
80+ 117/1208 14.7 7/42 16.7
All ages 713/17225 4.1 18/260 6.9
Discussion
In this investigation essentially the same methods were
applied as in our previous study in which they were critically
reviewed (Adami et al., 1984). Several characteristics of the
design indicate that the internal validity is acceptable.
Virtually all cases in a defined population could be included
and subjected to complete follow-up. The endometrial
cancers observed and the number expected were both derived
from the National Cancer Registry, which has a low
frequency of undernotification (Mattson, 1977; Mattson &
Wallgren, 1984).
The risk of false positive results - which inclusion of a
subgroup with a random high outcome might entail - was
minimized by excluding the period 1964 through 1967 during
which our previous cohort was recruited (Adami et al.,
1984). Breast cancers diagnosed during that period were thus
used only to genermte the hypothesis which was further
tested in a differcnit imiaterial in the present study. Still, the
size of the cohort and the duration of follow-up provided us
with a sufficiently large number of cases to make the risk of
false negative findings reasonably low. The possibility of a
higher detection rate of endometrial cancer in breast cancer
patients than in the general population due to closer medical
surveillance cannot be definitely excluded. The assumption
that such a bias should operate particularly in older women
is, however, contradicted by the absence of a similar trend
towards increased risk at higher ages for cancer of the
ovaries, colon and rectum (Adami et al., 1984). In addition,
vaginal bleeding - which is the first evidence of endometrial
cancer- is a dramatic event in postmenopausal women. The
impact of patient and doctors delay should therefore be
small.
In Sweden radiation-induced menopause has been used as
an adjuvant treatment only occasionally in pre- and
perimiienopausal women with breast cancer and would thus
not affect the risk of endometrial cancer in older women.
Hormonal treatment has been used for palliation only in
advanced cases with too short survival time for an oestrogen
induced endometrial cancer to develop. A confounding effect
of radiation to the pelvic area or of oestrogen treatment is
therefore unlikely (Ewertz et al., 1984).
The present data confirm our earlier observation that the
risk of developing endometrial cancer is increased in breast
cancer patients and that this characteristic pertains primarily
to older women. This finding, which is in accordance with
an earlier report based on a small number of observed cases
(MacMahon & Austin, 1969) was extended, furthermore, by
the observation of a regular increase in risk with age, the
relative risk in women older than seventy years being two to
three times higher than that in women under fifty. Moreover,
there is seemingly a strong temporal correlation in the
occurrence of malignant disease at these two sites; the excess
risk was largely confined to the first five years after the
breast cancer diagnosis and a substantial proportion of the
endometrial cancers become manifest clinically within one
year of observation.
The interpretation of these findings is not straightforward.
However, the strength and age-dependence of the increased
risk and the temporal correlation in the occurrence of the
disease suggest that breast and endometrial cancers have at
least one aetiologic factor in common, that this factor is not
operative at premenopausal ages but becomes increasingly
more important after the age of fifty, and that the initiation
or promotion of neoplastic growth is synchronized so that
the cancers develop to clinical size at about the same period
of time.
In principle, causative factors can be genetic or
environmental. Earlier studies have shown that familial
occurrence of breast cancer is not a common feature in this
population. Among women who had a sister with breast
cancer the risk of cancer at this site was doubled, whereas
the relative risk among those whose mother had had the
disease was non-significantly increased to 1.4 (Adami et al.,
1981). We concluded from these findings that environmental
rather than genetic factors might account for the aggregation
of breast cancer within certain families and exert their effect
more homogeneously on relatives from the same generation
than on those from consecutive generations. With this
evidence that genetic determinants only play a minor role -
if any - in the occurrence of breast cancer in general, it
seems unlikely that they would be of importance for the
cases in which endometrial cancer also occurs - especially
given that these cases seem to occur mainly in relatively old
women (Table II) which appears not to be true of familial
breast cancer (Anderson, 1974; Adami et al., 1981). Our
discussion therefore has to be focused on the possible nature
of common environmental factors for breast and endometrial
cancer in older women.
The aetiology of cancer in endocrine target organs has
traditionally been sought - with limited progress so far -
wvithin the paradigm of hormonal expressions of
characteristics of reproductive life or, more recently, in
dietary habits (Dunn, 1975; Cole & Cramer, 1977; Howe et
al., 1984; Henderson et al., 1982; Willett & MacMahon,
1984). It seems unsolved whether the elevated risk of breast
cancer in women of low parity and in those of high age at80 H.-O. ADAMI el al.
first birth represents a causal relationship (Kelsey &
Hildreth, 1983; Adami et al., 1980). Moreover, there is no
indication from our data or from others that this association
becomes more pronounced with increasing age.
In endometrial cancer, on the other hand, a causal
relationship with certain characteristics of the reproductive
history (Ewertz et al., 1984; Kelsey & Hildreth, 1983;
Pettersson et al., 1986) excess endogenous oestrogens
(Henderson et al., 1982) and with oestrogen therapy (Ewertz
et al., 1984; Persson et al., 1986; Zeil, 1982) seems to be
more firmly established. We have recently found that the
relation between a long menstruation span - defined as the
period between menarche and menopause, adjusted for
anovulatory periods during parity and lactation - and an
increased risk of endometrial cancer is negatively correlated
with age at diagnosis (Pettersson et al., 1986). The term
mcnstruation span has been introduced to reflect the number
of menstrual cycles in a woman's life and thus summarizes
several factors which proposedly may influence the risk of
both breast and endometrial cancer. Nevertheless, the
enhanced risk of endometrial cancer secondary to a long
menstruation span virtually disappears after the age of
seventy (Pettersson et al., 1986), when the association
between breast and endometrial cancer reaches its maximum.
In conclusion, there is no obvious common risk factor
related to reproducive life which could give a reasonable
explanation for the age-dependent association between
cancer of the breast and cancer of the endometrium. There is
some support, rather, for the view that in this population
such factors are of little importance for the occurrence of at
least endometrial cancer in older women.
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